| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | - | 41.326 | 170.379 |
| Total Income - EUR | - | - | - | - | - | - | - | - | 42.013 | 170.379 |
| Total Expenses - EUR | - | - | - | - | - | - | - | - | 42.504 | 164.107 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | - | -491 | 6.272 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | - | -983 | 1.811 |
| Employees | - | - | - | - | - | - | - | - | 1 | 1 |
Check the financial reports for the company - Fitofarm Adunati S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | - | 0 | 20.134 |
| Current Assets | - | - | - | - | - | - | - | - | 108.356 | 102.459 |
| Inventories | - | - | - | - | - | - | - | - | 70.197 | 90.571 |
| Receivables | - | - | - | - | - | - | - | - | 7.019 | 8.787 |
| Cash | - | - | - | - | - | - | - | - | 31.141 | 3.101 |
| Shareholders Funds | - | - | - | - | - | - | - | - | -942 | 874 |
| Social Capital | - | - | - | - | - | - | - | - | 40 | 40 |
| Debts | - | - | - | - | - | - | - | - | 109.299 | 121.719 |
| Income in Advance | - | - | - | - | - | - | - | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4621 - 4621" | |||||||||
| CAEN Financial Year |
4621
|
|||||||||
Comments - Fitofarm Adunati S.r.l.